Show simple item record

dc.contributor.authorTree, A
dc.contributor.authorHuddart, R
dc.contributor.authorChoudhury, Ananya
dc.date.accessioned2018-10-21T16:41:50Z
dc.date.available2018-10-21T16:41:50Z
dc.date.issued2018-11
dc.identifier.citationMagnetic resonance-guided radiotherapy - can we justify more expensive technology? 2018, 30(11): 677-679 Clin Oncol (R Coll Radiol)en
dc.identifier.issn1433-2981
dc.identifier.pmid30217480
dc.identifier.doi10.1016/j.clon.2018.08.013
dc.identifier.urihttp://hdl.handle.net/10541/621295
dc.language.isoenen
dc.rightsArchived with thanks to Clinical oncology (Royal College of Radiologists (Great Britain))en
dc.titleMagnetic resonance-guided radiotherapy - can we justify more expensive technology?en
dc.typeArticleen
dc.contributor.departmentRoyal Marsden NHS Foundation Trust, Institute of Cancer Research, London, UKen
dc.identifier.journalClinical Oncologyen


Files in this item

This item appears in the following Collection(s)

Show simple item record